Results 11 to 20 of about 164 (138)
International Journal of Cancer, EarlyView.What's New? The CDK4/6 inhibitor ribociclib in combination with an endocrine‐based therapy has demonstrated significant progression‐free and overall survival benefits in patients with advanced/metastatic HR+/HER2‐ breast cancer in the pivotal MONALEESA trials.
Peter A. Fasching +20 more
wiley +1 more source
Journal of Clinical Ultrasound, EarlyView.In children with presumptive tuberculosis, comprehensive point‐of‐care (cPOCUS) identified key thoracic abnormalities with high specificity and excellent inter‐reader reliability. Although diagnostic sensitivity was modest and examinations often incomplete, cPOCUS shows promise as a complementary, radiation‐free imaging tool.
Isabelle Munyangaju +17 more
wiley +1 more source
Long‐term outcomes following a 5‐year recurrence‐free interval in non‐muscle‐invasive bladder cancer
BJU International, EarlyView.Objective To describe the recurrence and progression trends of non‐muscle‐invasive bladder cancer (NMIBC) during a 14‐year period in Denmark between 2009 and 2022. Furthermore, to evaluate the risk of late recurrence with or without progression in patients who initially experience a 5‐year recurrence‐free interval (RFI).
Peter B. Hjort +2 more
wiley +1 more source
Patient‐reported outcomes: active surveillance vs radical therapies in low‐risk prostate cancer
BJU International, Volume 137, Issue 4, Page 716-727, April 2026.Objective To prospectively evaluate functional patient‐reported outcomes (PROs) in patients with low‐risk prostate cancer (PCa) managed with active surveillance (AS), nerve‐sparing radical prostatectomy (NS‐RP), non‐NS‐RP, or radiotherapy (RT). Patients and Methods This multicentre prospective cohort study used data from the Prostate Cancer Outcomes ...
Mulham Al‐Nader +43 more
wiley +1 more source
Cervical Cancer Elimination in Australia and the Asia Pacific: Progress and Barriers
Medical Journal of Australia, Volume 224, Issue 4, April 2026.ABSTRACT Australia has been at the forefront of innovation and implementation of cervical cancer control and is predicted to eliminate cervical cancer by 2035, the first country to achieve elimination using active measures. This is a result of Australia being an early adopter of universal human papillomavirus (HPV) vaccination and early transition to a
Susan Yuill +6 more
wiley +1 more source
, 2009 A search for variable stars with ultra-low amplitudes (ULA), in the millimag range, has been made in the combined MACHO and OGLE data bases in the broad vicinity of the Cepheid instability strip in the HR diagram. A total of 25 singly periodic and 4 multiply periodic ULA objects has been uncovered.
Buchler, J. Robert +2 more
openaire +2 more sources
International Journal of Cancer, Volume 158, Issue 6, Page 1690-1702, 15 March 2026.What's new? The current standard of care for locally advanced or metastatic renal cell carcinoma (aRCC) is either a combination of two immune checkpoint inhibitors (CPI) or a CPI plus a tyrosine kinase inhibitor (TKI). Here, the authors simulate a head‐to‐head trial comparing the real‐world effectiveness of these combination therapies with TKI ...
Peter J. Goebell +15 more
wiley +1 more source
The luminosity scale of Cepheid variable stars - A revison
The Astrophysical Journal, 1984 The period-luminosity-color relation for classical Cepheids is discussed in terms of a recent redeterminations of the distance moduli of open clusters with Cepheid members. The distance moduli of eight clusters with well established Cepheid members were determined from Stromgren four-color and Hp photometry of the B stars.
openaire +1 more source
Variable Stars in Leo A: RR Lyrae Stars, Short-Period Cepheids, and Implications for Stellar Content
The Astronomical Journal, 2002 46 pages, 12 figures Accepted by ...
Dolphin, AE +8 more
openaire +3 more sources
Cancer Medicine, Volume 15, Issue 3, March 2026.ABSTRACT Objective To investigate cardiovascular disease (CVD) mortality patterns among people with cancer in New South Wales (NSW) compared to the NSW general population and trends over time. Design Population‐wide retrospective data‐linkage study. Participants and Setting 873,344 people aged ≥ 40 diagnosed with primary invasive cancer and registered ...
Md Mijanur Rahman +9 more
wiley +1 more source